Global Veterinary Biologics Market Top Major Players 2024, Forecast To 2033
8 Mar, 2024
The veterinary biologics market has demonstrated strong growth, increasing from $11.77 billion in 2023 to $12.78 billion in 2024, with a CAGR of 8.6%. This growth is driven by factors such as animal disease outbreaks, regulatory support, and the globalization of trade. Forecasts predict further expansion, reaching $17.11 billion by 2028, with a CAGR of 7.6%. Emerging trends include education programs, sustainable biologics, digital health records integration, and customized therapies catering to companion animals and livestock.
Global Veterinary Biologics Market Key Driver
The veterinary biologics market is witnessing growth propelled by the rising prevalence of animal diseases worldwide. Animal diseases pose significant health risks to various animal species, necessitating effective diagnostic and treatment solutions such as veterinary biologics. With outbreaks of avian influenza and rabies reported globally, as documented by the European Center for Disease Prevention and Control and the World Health Organization, respectively, the demand for veterinary biologics is expected to rise, driven by the imperative to address the increasing prevalence of animal diseases.
Get A Free Sample Of The Global Veterinary Biologics Market ReportGlobal Veterinary Biologics Market Segments
The veterinary biologics market covered in this report is segmented –
1) Product:Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
2) Disease Type:Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases
3) Distribution Channel:Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
4) Application:Production Animal, Companion Animal
By Geography: The countries covered in the veterinary biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the veterinary biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Veterinary Biologics Industry Players
Bayer AG; Eli Lilly & Company;Evonik Industries AG; Zoetis Inc.; VCA Inc.; Merck Animal Health Inc.; Boehringer Ingelheim Animal Health Inc.; Elanco Animal Health; IDEXX Laboratories Inc.; Nutreco N.V.; Virbac SA; Hologic Inc.; Phibro Animal Health Corporation; Vetoquinol; Valneva; Abaxis Inc.; Bimeda Biologicals; Ceva Sante Animale S.A.; Heska Corporation; Heska Corporation; Colorado Serum Company; Hester Biosciences Limited; INDICAL Bioscience GmbH; Ambrx Biopharma Inc.; Adamis Pharmaceuticals Corporation; Intervet Inc.; Hebei Veyong Animal Pharmaceutical Co. Ltd.;FidoCure; Biomet Biologics LLC; CytoDyn Veterinary Medicine LLC; KM Biologics
Get The Full Global Veterinary Biologics Market Report
Veterinary Biologics Market Overview
Veterinary biologics refers to biological products derived from living organisms, such as bacteria, viruses, or other microorganisms. Veterinary biologics are used in veterinary medicine to prevent, diagnose, or treat animal diseases.